Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T13:25:29.371Z.
Calculation as of: 2026-10-06T13:25:29.371Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 83c64da899843448fde498cf5e629ee28b7cf55c7878198a0aebccb75d14602d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-08-13.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
EBITDA YIELD AVG TTM
N/A
EBITDA YIELD AVG 3Y
N/A
EBITDA YIELD AVG 5Y
N/A
EBITDA YIELD AVG 10Y
N/A
EBITDA YIELD AVG 15Y
N/A
EBITDA YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Aspire Biopharma Holdings, Inc.
Market Cap
$1.02M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$878396.00
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | $1.02M | N/A | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | 0.07% | 0.06% | 0.06% |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | 8.30% | 8.30% | 8.30% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.17M | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $787624.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $707297.00 | 24.23% | 13.08% | 19.90% | 19.90% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA YIELD |
|---|---|
| 2026-08-13 | 66.37% |
| 2026-08-12 | 66.06% |
| 2026-08-11 | 59.30% |
| 2026-08-10 | 57.11% |
| 2026-08-07 | 57.82% |
| 2026-08-06 | 67.17% |
| 2026-08-05 | 64.08% |
| 2026-08-04 | 67.50% |
| 2026-08-03 | 64.53% |
| 2026-07-31 | 77.23% |
| 2026-07-30 | 73.17% |
| 2026-07-29 | 103.31% |
| 2026-07-28 | 64.23% |
| 2026-07-27 | 68.66% |
| 2026-07-24 | 64.08% |
| 2026-07-23 | 64.83% |
| 2026-07-22 | 57.47% |
| 2026-07-21 | 60.20% |
| 2026-07-20 | 75.97% |
| 2026-07-17 | 83.74% |
| 2026-07-16 | 82.74% |
| 2026-07-15 | 89.10% |
| 2026-07-14 | 89.38% |
| 2026-07-13 | 91.14% |
| 2026-07-10 | 89.96% |
| 2026-07-09 | 88.25% |
| 2026-07-08 | 97.18% |
| 2026-07-07 | 103.31% |
| 2026-07-06 | 93.90% |
| 2026-07-02 | 84.50% |
| 2026-07-01 | 94.54% |
| 2026-06-30 | 114.82% |
| 2026-06-29 | 86.33% |
| 2026-06-26 | 90.25% |
| 2026-06-25 | 78.54% |
| 2026-06-24 | 76.81% |
| 2026-06-23 | 85.54% |
| 2026-06-22 | 82.50% |
| 2026-06-18 | 75.97% |
| 2026-06-17 | 80.82% |
| 2026-06-16 | 85.02% |
| 2026-06-15 | 101.80% |
| 2026-06-12 | 136.15% |
| 2026-06-11 | 90.25% |
| 2026-06-10 | 103.31% |
| 2026-06-09 | 91.14% |
| 2026-06-08 | 74.55% |
| 2026-06-05 | 114.82% |
| 2026-06-04 | 88.81% |
| 2026-06-03 | 95.19% |
| 2026-06-02 | 89.67% |
| 2026-06-01 | 91.44% |
| 2026-05-29 | 108.13% |
| 2026-05-28 | 106.47% |
| 2026-05-27 | 158.65% |
| 2026-05-26 | 129.20% |
| 2026-05-22 | 111.59% |
| 2026-05-21 | 104.09% |
| 2026-05-20 | 89.38% |
| 2026-05-19 | 95.52% |
| 2026-05-18 | 73.95% |
